These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32169875)

  • 21. Overweight and obesity as risk factors for cervical cancer and detection of precancers among screened women: A nationwide, population-based cohort study.
    Urbute A; Frederiksen K; Thomsen LT; Kesmodel US; Kjaer SK
    Gynecol Oncol; 2024 Feb; 181():20-27. PubMed ID: 38103421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
    Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer in Jewish women.
    Glezerman M; Piura B; Insler V
    Am J Obstet Gynecol; 1989 Nov; 161(5):1186-90. PubMed ID: 2589437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women.
    Keinan-Boker L; Levine H; Derazne E; Molina-Hazan V; Kark JD
    Breast Cancer Res Treat; 2016 Jul; 158(1):157-167. PubMed ID: 27306419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia.
    Holy O; Machaczka O; Schovankova T; Navratilova D; Zimmermannova J; Klasterecka R; Vevoda J
    Front Public Health; 2024; 12():1347800. PubMed ID: 38813429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors for thyroid carcinoma in Israel: a national cohort of 1,624,310 adolescents followed for up to 40 years.
    Farfel A; Kark JD; Derazne E; Tzur D; Barchana M; Lazar L; Afek A; Shamiss A
    Thyroid; 2014 Jun; 24(6):987-93. PubMed ID: 24483833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
    Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
    Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical intraepithelial neoplasia and associated condylomatous lesions. A preliminary report on 4,764 women from Northern Israel.
    Suprun HZ; Schwartz J; Spira H
    Acta Cytol; 1985; 29(3):334-40. PubMed ID: 3859132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).
    Melan K; Janky E; Macni J; Ulric-Gervaise S; Dorival MJ; Veronique-Baudin J; Joachim C
    Glob Health Action; 2017; 10(1):1337341. PubMed ID: 28649938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body mass index at adolescence and risk of noncardia gastric cancer in a cohort of 1.79 million men and women.
    Levi Z; Kark JD; Twig G; Katz L; Leiba A; Derazne E; Tzur D; Liphshitz I; Keinan-Boker L; Afek A
    Cancer; 2018 Jan; 124(2):356-363. PubMed ID: 29053193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
    Liu G; Sharma M; Tan N; Barnabas RV
    AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence trends of cervical adenocarcinoma in Israeli Jewish women. A population-based study.
    Menczer J; Kogan L; Liphshiz I; Barchana M
    Acta Obstet Gynecol Scand; 2009; 88(3):280-5. PubMed ID: 19172425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CERVICAL CANCER IN ISRAEL 2016: FACTS, INSIGHTS AND THOUGHTS FOR THE FUTURE].
    Fisher M; Schejter E; Solt I; Renart G
    Harefuah; 2016 Sep; 155(9):563-566. PubMed ID: 28530082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents.
    Katz LH; Levi Z; Twig G; Kark JD; Leiba A; Derazne E; Liphshiz I; Keinan-Boker L; Eisenstein S; Afek A
    Int J Cancer; 2018 Oct; 143(8):1876-1883. PubMed ID: 29744856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.